查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1650414

视网膜静脉阻塞市场；治疗类型：- 2024 年至 2034 年全球产业分析、规模、份额、成长、趋势与预测

Retinal Vein Occlusion Market; Treatment Type: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 241 Pages | 商品交期: 2-10个工作天内

价格

视网膜静脉阻塞市场 - 报告范围

TMR 关于全球视网膜静脉阻塞市场的报告研究了过去和当前的成长趋势和机会，以便在 2024 年至 2034 年预测期内获得有关市场指标的宝贵见解。 该报告提供了 2018 年至 2034 年期间全球视网膜静脉阻塞市场的收入，以 2024 年为基准该报告也提供了 2024 年至 2034 年全球视网膜静脉阻塞市场的年复合成长率(CAGR%)。

该报告是经过广泛研究后编写的。初步研究涉及大部分研究工作，其中分析师对关键意见领袖、产业领袖和舆论製造者进行访谈。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解视网膜静脉阻塞市场。

市场概况
2023 年市场价值 28亿美元
2034 年的市场价值 55亿美元
复合年增长率 6.7%

该报告深入探讨了全球视网膜静脉阻塞市场的竞争格局。我们已经确定了在全球视网膜静脉阻塞市场中运作的关键参与者，并根据各种属性对每位参与者进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告介绍的全球视网膜静脉阻塞市场参与者的属性。

目录

第 1 章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第四章：市场概况

  • 介绍
  • 概述
  • 市场动态
  • 2020 年至 2034 年全球市场分析与预测

第五章：关键见解

  • 监管情景
  • 大环境分析
  • 各地区/国家医疗保健支出（人均医疗保健支出总额，美元，2022 年）
  • 市场进入策略
  • 价值链分析
  • 治疗演算法
  • 重要产业活动

第六章：全球市场分析与预测：依疾病类型

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2034 年按疾病类型分類的市场价值预测
    • 中央
    • 分支
  • 不同疾病类型的市场吸引力

第七章：全球市场分析及预测：依治疗类型

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2034 年按治疗类型分類的市场价值预测
    • 药物治疗
      • 抗血管内皮生长因子（抗 VEGF）药物
      • 皮质类固醇药物
    • 雷射治疗
      • 全视网膜光凝固术
      • 聚焦雷射
    • 玻璃体切除术
  • 各治疗类型的市场吸引力

第 8 章：全球市场分析与预测：按最终用户

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2034 年终端用户市值预测
    • 医院及门诊手术中心
    • 眼科诊所
    • 零售药局
    • 其他的
  • 终端用户的市场吸引力

第九章：全球市场分析及预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第 10 章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第 12 章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太其他地区

第 13 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：按公司（2023 年）
  • 公司简介
    • Bayer AG
    • Alimera Sciences
    • Abbivie
    • Annexin Pharmaceuticals AB
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • IRIDEX Corporation
    • Lumenis
    • Nidek Co., Ltd.
    • Regeneron Pharmaceuticals, Inc.
Product Code: TMRGL60489

Retinal Vein Occlusion Market - Scope of Report

TMR's report on the global retinal vein occlusion market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global retinal vein occlusion market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global retinal vein occlusion market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the retinal vein occlusion market.

Market Snapshot
Market Value in 2023US$ 2.8 Bn
Market Value in 2034US$ 5.5 Bn
CAGR6.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global retinal vein occlusion market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global retinal vein occlusion market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global retinal vein occlusion market.

The report delves into the competitive landscape of the global retinal vein occlusion market. Key players operating in the global retinal vein occlusion market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global retinal vein occlusion market profiled in this report.

Key Questions Answered in Global retinal vein occlusion Market Report:

  • What is the sales/revenue generated by retinal vein occlusion across all regions during the forecast period?
  • What are the opportunities in the global retinal vein occlusion market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Retinal Vein Occlusion Market - Research Objectives and Research Approach

The comprehensive report on the global retinal vein occlusion market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global retinal vein occlusion market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global retinal vein occlusion market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Retinal Vein Occlusion Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Retinal Vein Occlusion Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Scenario
  • 5.2. PESTLE Analysis
  • 5.3. Healthcare Expenditure by Region/Country (Health spending Total, US dollars/capita, 2022)
  • 5.4. Go-to-Market Strategies for Retinal Vein Occlusion Market
  • 5.5. Value Chain Analysis
  • 5.6. Treatment Algorithm
  • 5.7. Key Industry Events

6. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Disease Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Disease Type, 2020-2034
    • 6.3.1. Central Retinal Vein Occlusion
    • 6.3.2. Branch Retinal Vein Occlusion
  • 6.4. Market Attractiveness By Disease Type

7. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Treatment Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Treatment Type, 2020-2034
    • 7.3.1. Pharmacological Treatment
      • 7.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 7.3.1.2. Corticosteroid Drugs
    • 7.3.2. Laser Treatment
      • 7.3.2.1. Panretinal Photocoagulation
      • 7.3.2.2. Focal Laser
    • 7.3.3. Vitrectomy
  • 7.4. Market Attractiveness By Treatment Type

8. Global Retinal Vein Occlusion Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospitals and Ambulatory Surgical Centers
    • 8.3.2. Ophthalmology Clinics
    • 8.3.3. Retail Pharmacies
    • 8.3.4. Others
  • 8.4. Market Attractiveness By End-user

9. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Retinal Vein Occlusion Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Disease Type, 2020-2034
    • 10.2.1. Central Retinal Vein Occlusion
    • 10.2.2. Branch Retinal Vein Occlusion
  • 10.3. Market Value Forecast By Treatment Type, 2020-2034
    • 10.3.1. Pharmacological Treatment
      • 10.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 10.3.1.2. Corticosteroid Drugs
    • 10.3.2. Laser Treatment
      • 10.3.2.1. Panretinal Photocoagulation
      • 10.3.2.2. Focal Laser
    • 10.3.3. Vitrectomy
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospitals and Ambulatory Surgical Centers
    • 10.4.2. Ophthalmology Clinics
    • 10.4.3. Retail Pharmacies
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Disease Type
    • 10.6.2. By Treatment Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Retinal Vein Occlusion Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Disease Type, 2020-2034
    • 11.2.1. Central Retinal Vein Occlusion
    • 11.2.2. Branch Retinal Vein Occlusion
  • 11.3. Market Value Forecast By Treatment Type, 2020-2034
    • 11.3.1. Pharmacological Treatment
      • 11.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 11.3.1.2. Corticosteroid Drugs
    • 11.3.2. Laser Treatment
      • 11.3.2.1. Panretinal Photocoagulation
      • 11.3.2.2. Focal Laser
    • 11.3.3. Vitrectomy
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospitals and Ambulatory Surgical Centers
    • 11.4.2. Ophthalmology Clinics
    • 11.4.3. Retail Pharmacies
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Disease Type
    • 11.6.2. By Treatment Type
    • 11.6.3. By End-user
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Retinal Vein Occlusion Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Disease Type, 2020-2034
    • 12.2.1. Central Retinal Vein Occlusion
    • 12.2.2. Branch Retinal Vein Occlusion
  • 12.3. Market Value Forecast By Treatment Type, 2020-2034
    • 12.3.1. Pharmacological Treatment
      • 12.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 12.3.1.2. Corticosteroid Drugs
    • 12.3.2. Laser Treatment
      • 12.3.2.1. Panretinal Photocoagulation
      • 12.3.2.2. Focal Laser
    • 12.3.3. Vitrectomy
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospitals and Ambulatory Surgical Centers
    • 12.4.2. Ophthalmology Clinics
    • 12.4.3. Retail Pharmacies
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Disease Type
    • 12.6.2. By Treatment Type
    • 12.6.3. By End-user
    • 12.6.4. By Country / Sub-region

13. Latin America Retinal Vein Occlusion Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Disease Type, 2020-2034
    • 13.2.1. Central Retinal Vein Occlusion
    • 13.2.2. Branch Retinal Vein Occlusion
  • 13.3. Market Value Forecast By Treatment Type, 2020-2034
    • 13.3.1. Pharmacological Treatment
      • 13.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 13.3.1.2. Corticosteroid Drugs
    • 13.3.2. Laser Treatment
      • 13.3.2.1. Panretinal Photocoagulation
      • 13.3.2.2. Focal Laser
    • 13.3.3. Vitrectomy
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospitals and Ambulatory Surgical Centers
    • 13.4.2. Ophthalmology Clinics
    • 13.4.3. Retail Pharmacies
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Disease Type
    • 13.6.2. By Treatment Type
    • 13.6.3. By End-user
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Retinal Vein Occlusion Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Disease Type, 2020-2034
    • 14.2.1. Central Retinal Vein Occlusion
    • 14.2.2. Branch Retinal Vein Occlusion
  • 14.3. Market Value Forecast By Treatment Type, 2020-2034
    • 14.3.1. Pharmacological Treatment
      • 14.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 14.3.1.2. Corticosteroid Drugs
    • 14.3.2. Laser Treatment
      • 14.3.2.1. Panretinal Photocoagulation
      • 14.3.2.2. Focal Laser
    • 14.3.3. Vitrectomy
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospitals and Ambulatory Surgical Centers
    • 14.4.2. Ophthalmology Clinics
    • 14.4.3. Retail Pharmacies
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Disease Type
    • 14.6.2. By Treatment Type
    • 14.6.3. By End-user
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Alimera Sciences
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Abbivie
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Annexin Pharmaceuticals AB
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. F. Hoffmann-La Roche AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Novartis AG
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. IRIDEX Corporation
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Lumenis
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Nidek Co., Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Regeneron Pharmaceuticals, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments

Retinal Vein Occlusion Market

Retinal Vein Occlusion Industry

Retinal Vein Occlusion Market Size

Retinal Vein Occlusion Market Share

Retinal Vein Occlusion Market Growth

Retinal Vein Occlusion Market Analysis

Retinal Vein Occlusion Market Demand

Retinal Vein Occlusion Market Forecast

Retinal Vein Occlusion Market Trends

List of Tables

  • Table 01: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Disease Type, 2020-2034
  • Table 02: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 03: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 04: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 05: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By End-user, 2020-2034
  • Table 06: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Region, 2020-2034
  • Table 07: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 08: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 09: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 10: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 11: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 12: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 15: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 16: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 17: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 18: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 19: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 20: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 21: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 22: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 23: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 24: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 25: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 27: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 28: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 29: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 30: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 31: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 32: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 33: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 34: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 35: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 36: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Retinal Vein Occlusion Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Retinal Vein Occlusion Market Value Share, by Disease Type, 2023
  • Figure 03: Global Retinal Vein Occlusion Market Value Share, By Treatment Type, 2023
  • Figure 04: Global Retinal Vein Occlusion Market Value Share, by End-user, 2023
  • Figure 05: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Disease Type, 2023 and 2034
  • Figure 06: Global Retinal Vein Occlusion Market Share Analysis, By Disease Type, 2023
  • Figure 07: Global Retinal Vein Occlusion Market Share Analysis, By Disease Type, 2034
  • Figure 08: Global Retinal Vein Occlusion Market Attractiveness Analysis, By Disease Type, 2024-2034
  • Figure 09: Global Retinal Vein Occlusion Market Value (US$ Bn), by Central Retinal Vein Occlusion, 2020-2034
  • Figure 10: Global Retinal Vein Occlusion Market Value Share Analysis, by Central Retinal Vein Occlusion, 2023 and 2034
  • Figure 11: Global Retinal Vein Occlusion Market Value (US$ Bn), by Branch Retinal Vein Occlusion, 2020-2034
  • Figure 12: Global Retinal Vein Occlusion Market Value Share Analysis, by Branch Retinal Vein Occlusion, 2023 and 2034
  • Figure 13: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 14: Global Retinal Vein Occlusion Market Share Analysis, By Treatment Type, 2023
  • Figure 15: Global Retinal Vein Occlusion Market Share Analysis, By Treatment Type, 2034
  • Figure 16: Global Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 17: Global Retinal Vein Occlusion Market Value (US$ Bn), by Pharmacological Treatment, 2020-2034
  • Figure 18: Global Retinal Vein Occlusion Market Value Share Analysis, by Pharmacological Treatment, 2023 and 2034
  • Figure 19: Global Retinal Vein Occlusion Market Value (US$ Bn), by Laser Treatment, 2020-2034
  • Figure 20-: Global Retinal Vein Occlusion Market Value Share Analysis, by Laser Treatment, 2023 and 2034
  • Figure 21: Global Retinal Vein Occlusion Market Value (US$ Bn), by Vitrectomy, 2020-2034
  • Figure 22: Global Retinal Vein Occlusion Market Value Share Analysis, by Vitrectomy, 2023 and 2034
  • Figure 23: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By End-user, 2023 and 2034
  • Figure 24: Global Retinal Vein Occlusion Market Share Analysis, By End-user, 2023
  • Figure 25: Global Retinal Vein Occlusion Market Share Analysis, By End-user, 2034
  • Figure 26: Global Retinal Vein Occlusion Market Attractiveness Analysis, By End-user, 2024-2034
  • Figure 27: Global Retinal Vein Occlusion Market Value (US$ Bn), by Hospitals and Ambulatory Surgical Centers, 2020-2034
  • Figure 28: Global Retinal Vein Occlusion Market Value Share Analysis, by Hospitals and Ambulatory Surgical Centers, 2023 and 2034
  • Figure 29: Global Retinal Vein Occlusion Market Value (US$ Bn), by Ophthalmology Clinics, 2020-2034
  • Figure 30: Global Retinal Vein Occlusion Market Value Share Analysis, by Ophthalmology Clinics, 2023 and 2034
  • Figure 31: Global Retinal Vein Occlusion Market Value (US$ Bn), by Retail Pharmacies, 2020-2034
  • Figure 32: Global Retinal Vein Occlusion Market Value Share Analysis, by Retail Pharmacies, 2023 and 2034
  • Figure 33: Global Retinal Vein Occlusion Market Value (US$ Bn), By Others, 2020-2034
  • Figure 34: Global Retinal Vein Occlusion Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 35: Global Retinal Vein Occlusion Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 36: Global Retinal Vein Occlusion Market Share Analysis, by Region, 2023
  • Figure 37: Global Retinal Vein Occlusion Market Share Analysis, by Region, 2034
  • Figure 38: Global Retinal Vein Occlusion Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 39: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 40: North America Retinal Vein Occlusion Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 41: North America Retinal Vein Occlusion Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 42: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 43: North America Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 44: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 45: North America Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 46: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 47: North America Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 48: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 49: Europe Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 50: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 51: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 52: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 53: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 54: Europe Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 55: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 56: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 57: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 58: Asia Pacific Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 59: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 60: Asia Pacific- Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 61: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 62: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 63: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 64: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 65: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 67: Latin America Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 69: Asia Pacific- Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 70: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 71: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 72: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 73: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 74: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 75: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 76: Middle East & Africa Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 77: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 78: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 79: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 80: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 81: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 82: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 83: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034